Yi Xu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yi Xu has a total of 81 co-authors. Here are the top co-authors by number of shared publications:
Hengxin Han
16 shared publicationsHangyu Dang
13 shared publications- Taijie Zhan
Institute of Biothermal Science and Technology
10 shared publications Mengdong Cui
Institute of Biothermal Science and Technology University of Shanghai for Science and Technology Shanghai China
7 shared publicationsTaijie Zhan
Institute of Bio-thermal Science and Technology, Shanghai Co-innovation Center for Energy Therapy of Tumors, Shanghai Technical Service Platform for Cryopreservation of Biological Resources, University of Shanghai for Science and Technology, Shanghai, 200093, China; School of Medical and Information Engineering, Jiangxi Provincial Key Laboratory of Tissue Engineering, Scientific Research Center, Gannan Medical University, Ganzhou, 341000, China
6 shared publicationsJinglong Zuo
5 shared publications
Latest Publications
- Open Access
- 12 October 2026
- Published by Elsevier in SSRN Electronic Journal
Airflow and Thermal Transport in a Rhythmically Expanding Acinar Duct under Hypothermic Ventilation: Implications for DCD Lung Preservation
Hypothermic ventilation is a potential method for preserving donation after circulatory death (DCD) lungs, but cooling in the distal airways remains limited. In this study, a three-dimensional acinar duct model (G18) was used to investigate airflow and heat transfer during rhythmic wall motion. Moving-wall and rigid-wall models were compared, and the effects of Reynolds number (Re), Womersley number (Wo), specific volume excursion (C), and inlet temperature (Ti) were considered. Numerical results indicate that wall motion changes the alveolar flow patterns and promotes radial transport between the lumen and alveolar cavities. As Re decreases from 0.5 to 0.005, the alveolar flow changes from mainly recirculating flow to radial flow, while the normalized velocity profiles show different responses in the lumen and alveoli. Lowering Ti reduces the local air temperature, but the temperature decrease is mainly confined to the inlet region. Changes in Re and wall motion have only a small effect on the temperature distribution. These findings clarify the different effects of wall motion on airflow and thermal transport and provide a basis for improving hypothermic ventilation in the distal airways of DCD lungs.
- 12 October 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessAirflow and Thermal Transport in a Rhythmically Expanding Acinar Duct under Hypothermic Ventilation: Implications for DCD Lung Preservation
Hypothermic ventilation is a potential method for preserving donation after circulatory death (DCD) lungs, but cooling in the distal airways remains limited. In this study, a three-dimensional acinar duct model (G18) was used to investigate airflow and heat transfer during rhythmic wall motion. Moving-wall and rigid-wall models were compared, and the effects of Reynolds number (Re), Womersley number (Wo), specific volume excursion (C), and inlet temperature (Ti) were considered. Numerical results indicate that wall motion changes the alveolar flow patterns and promotes radial transport between the lumen and alveolar cavities. As Re decreases from 0.5 to 0.005, the alveolar flow changes from mainly recirculating flow to radial flow, while the normalized velocity profiles show different responses in the lumen and alveoli. Lowering Ti reduces the local air temperature, but the temperature decrease is mainly confined to the inlet region. Changes in Re and wall motion have only a small effect on the temperature distribution. These findings clarify the different effects of wall motion on airflow and thermal transport and provide a basis for improving hypothermic ventilation in the distal airways of DCD lungs.
- 17 September 2026
- Published by Elsevier in Acta Biomaterialia
- Vol. 225, 711-724
Synergistic proline-based deep eutectic solvent enables low-toxicity microdroplet cryopreservation of 3D cell spheroids
- 17 September 2026
- Published by Elsevier in Acta Biomaterialia
- Vol. 225, 711-724
Synergistic proline-based deep eutectic solvent enables low-toxicity microdroplet cryopreservation of 3D cell spheroids
- Open Access
- 30 May 2026
- Published by Elsevier in Case Studies in Thermal Engineering
- Vol. 83
An integrated electromagnetic induction system for rapid and uniform rewarming in multi-well plate cryopreservation
- 30 May 2026
- Published by Elsevier in Case Studies in Thermal Engineering
- Vol. 83
Open AccessAn integrated electromagnetic induction system for rapid and uniform rewarming in multi-well plate cryopreservation
- 18 May 2026
- Published by Wiley in Macromolecular Bioscience
- Vol. 26 (5) , e70196
Study on HSA and Dex‐40 Mitigating Osmotic Damage in NK Cells During CPA Loading
Human natural killer (NK) cells represent promising therapeutic agents for cancer and immune diseases. However, cryopreservation‐induced stress leads to high post‐thaw mortality and impaired cytotoxic function. While cryoprotectant (CPA) loading is one of the most critical processes for subsequent cell preservation, the high osmotic pressure and chemical toxicity significantly compromise cell viability. Here, we investigate osmotic stress responses in primary PBNK cells during CPA loading under varying osmotic conditions. We develop a mathematical model to simulate the osmotic processes and water transport dynamics across the cell membrane and enable quantitative assessment of non‐osmotic protective components, i.e., Human Serum Albumin (HSA) and Dextran‐40 (Dex‐40). The experimental results demonstrate that our optimized protocol reduces osmotic and toxic stress damage by more than 30%. Simulation further indicates that HSA and Dex‐40 act synergistically to modulate membrane transport dynamics, reducing free water loss and stabilizing cell volume against osmotic damage. This work establishes the predictive model of CPA loading damage in NK cells, which is potential to provide a new perspective and approach for improving immune cell cryopreservation.
- 18 May 2026
- Published by Wiley in Macromolecular Bioscience
- Vol. 26 (5) , e70196
Study on HSA and Dex‐40 Mitigating Osmotic Damage in NK Cells During CPA Loading
Human natural killer (NK) cells represent promising therapeutic agents for cancer and immune diseases. However, cryopreservation‐induced stress leads to high post‐thaw mortality and impaired cytotoxic function. While cryoprotectant (CPA) loading is one of the most critical processes for subsequent cell preservation, the high osmotic pressure and chemical toxicity significantly compromise cell viability. Here, we investigate osmotic stress responses in primary PBNK cells during CPA loading under varying osmotic conditions. We develop a mathematical model to simulate the osmotic processes and water transport dynamics across the cell membrane and enable quantitative assessment of non‐osmotic protective components, i.e., Human Serum Albumin (HSA) and Dextran‐40 (Dex‐40). The experimental results demonstrate that our optimized protocol reduces osmotic and toxic stress damage by more than 30%. Simulation further indicates that HSA and Dex‐40 act synergistically to modulate membrane transport dynamics, reducing free water loss and stabilizing cell volume against osmotic damage. This work establishes the predictive model of CPA loading damage in NK cells, which is potential to provide a new perspective and approach for improving immune cell cryopreservation.
- 13 March 2026
- Published by American Chemical Society (ACS) in Langmuir
- Vol. 42 (12) , 8860-8873
Enhanced Preservation of HEK293T Cells and Rat Kidneys by Optimizing Double-Phase Isochoric Freezing with Active Nucleation Management
Isochoric freezing offers a CPA-free technique for low-temperature storage of biological samples, enhancing their stability, transportability, and potential for clinical organ transplantation. Conventional isochoric systems exploit the pressure-temperature coupling in a rigid, sealed chamber to suppress uncontrolled ice growth but lack precise spatiotemporal control over ice-nucleation events, leading to stochastic freezing and reduced preservation efficiency. Here, we present a double-phasic isochoric system that physically separates the sample chamber (sample solution) from an external nucleation chamber (freezing solution) and verify its stability across diverse liquid media, including pure water, saline, HTK, and UW. By introducing cholesterol-crystal nucleators into the freezing solution, we achieve controlled ice nucleation that directs crystal formation away from the sample chamber and generates endogenous pressure to sustain supercooling (43.8 ± 3.7 MPa at -4 °C), reducing random freezing incidence by 50%. After optimizing the sample container, we performed 24 h of isochoric freezing of HEK293T cells in 7 mL PE tubes at -4 °C, retaining 92 ± 3.1% viability; following 72 h, the cells exhibited superior proliferation and lower ROS damage compared with conventional 4 °C static cold storage (SCS). Applied to rat kidneys, 72 h of isochoric preservation decreased tissue malondialdehyde by 64 ± 6.2%, preserved Na+/K+-ATPase activity, and maintained histological integrity relative to SCS. This study establishes critical methodology for clinical translation of isochoric freezing and demonstrates its promise for extending organ preservation times and improving transplant viability.
- 13 March 2026
- Published by American Chemical Society (ACS) in Langmuir
- Vol. 42 (12) , 8860-8873
Enhanced Preservation of HEK293T Cells and Rat Kidneys by Optimizing Double-Phase Isochoric Freezing with Active Nucleation Management
Isochoric freezing offers a CPA-free technique for low-temperature storage of biological samples, enhancing their stability, transportability, and potential for clinical organ transplantation. Conventional isochoric systems exploit the pressure-temperature coupling in a rigid, sealed chamber to suppress uncontrolled ice growth but lack precise spatiotemporal control over ice-nucleation events, leading to stochastic freezing and reduced preservation efficiency. Here, we present a double-phasic isochoric system that physically separates the sample chamber (sample solution) from an external nucleation chamber (freezing solution) and verify its stability across diverse liquid media, including pure water, saline, HTK, and UW. By introducing cholesterol-crystal nucleators into the freezing solution, we achieve controlled ice nucleation that directs crystal formation away from the sample chamber and generates endogenous pressure to sustain supercooling (43.8 ± 3.7 MPa at -4 °C), reducing random freezing incidence by 50%. After optimizing the sample container, we performed 24 h of isochoric freezing of HEK293T cells in 7 mL PE tubes at -4 °C, retaining 92 ± 3.1% viability; following 72 h, the cells exhibited superior proliferation and lower ROS damage compared with conventional 4 °C static cold storage (SCS). Applied to rat kidneys, 72 h of isochoric preservation decreased tissue malondialdehyde by 64 ± 6.2%, preserved Na+/K+-ATPase activity, and maintained histological integrity relative to SCS. This study establishes critical methodology for clinical translation of isochoric freezing and demonstrates its promise for extending organ preservation times and improving transplant viability.
- 18 November 2025
- Published by American Chemical Society (ACS) in Langmuir
- Vol. 41 (47) , 32099-32109
Natural Deep Eutectic Solvents Enable Programmable Cooling-Free Cryopreservation
This study systematically evaluates two natural deep eutectic solvents (NADES)─PS21 (l-proline/sucrose, 2:1 molar ratio) and PS31 (l-proline/sucrose, 3:1 molar ratio)─as low-toxicity, programmable cooling-free cryoprotectants. Through comprehensive physicochemical characterization (FTIR, DSC, cryomicroscopy) and biological assays, we demonstrate that both PS21/PS31 variants significantly inhibit ice crystallization, modify ice morphology, and reduce recrystallization damage, and their unfrozen water content at 5 wt % (0.23 for PS21, 0.18 for PS31) was significantly higher than that of 10% dimethyl sulfoxide (DMSO, 0.10); cryomicroscopy revealed that NADES restrict ice crystal growth to 400-1000 μm2 (far smaller than the 4000-6000 μm2 in PBS) and modify ice morphology to reduce recrystallization damage. In biological assays using A549 cells: after 24 h of coculture, cell viability with 5 wt % PS31 (57.7%) was significantly higher than that with 10% DMSO(20.3%), and even at 20 wt %, PS21(18.6%) maintained viability comparable to DMSO. By optimizing cooling protocols (e.g., Method 2 with a cooling rate of -6.2 °C/min), high post-thaw performance was achieved: the highest survival rate (88.2%) was observed in the 15% PS31 group, and the 24 h proliferation rate of the 10% PS31 group reached 74.25%, significantly exceeding that of the DMSO group.These findings establish NADES as scalable, green alternatives for biobanking, offering streamlined workflows and enhanced sample quality while aligning with sustainable cryopreservation practices.
- 18 November 2025
- Published by American Chemical Society (ACS) in Langmuir
- Vol. 41 (47) , 32099-32109
Natural Deep Eutectic Solvents Enable Programmable Cooling-Free Cryopreservation
This study systematically evaluates two natural deep eutectic solvents (NADES)─PS21 (l-proline/sucrose, 2:1 molar ratio) and PS31 (l-proline/sucrose, 3:1 molar ratio)─as low-toxicity, programmable cooling-free cryoprotectants. Through comprehensive physicochemical characterization (FTIR, DSC, cryomicroscopy) and biological assays, we demonstrate that both PS21/PS31 variants significantly inhibit ice crystallization, modify ice morphology, and reduce recrystallization damage, and their unfrozen water content at 5 wt % (0.23 for PS21, 0.18 for PS31) was significantly higher than that of 10% dimethyl sulfoxide (DMSO, 0.10); cryomicroscopy revealed that NADES restrict ice crystal growth to 400-1000 μm2 (far smaller than the 4000-6000 μm2 in PBS) and modify ice morphology to reduce recrystallization damage. In biological assays using A549 cells: after 24 h of coculture, cell viability with 5 wt % PS31 (57.7%) was significantly higher than that with 10% DMSO(20.3%), and even at 20 wt %, PS21(18.6%) maintained viability comparable to DMSO. By optimizing cooling protocols (e.g., Method 2 with a cooling rate of -6.2 °C/min), high post-thaw performance was achieved: the highest survival rate (88.2%) was observed in the 15% PS31 group, and the 24 h proliferation rate of the 10% PS31 group reached 74.25%, significantly exceeding that of the DMSO group.These findings establish NADES as scalable, green alternatives for biobanking, offering streamlined workflows and enhanced sample quality while aligning with sustainable cryopreservation practices.
- 4 November 2025
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 333 (Pt 1) , 148773
Convergent evolution of a non-canonical bacterial antifreeze protein from Arctic Sea ice offers a blueprint for eco-friendly cryopreservation
- 4 November 2025
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 333 (Pt 1) , 148773
Convergent evolution of a non-canonical bacterial antifreeze protein from Arctic Sea ice offers a blueprint for eco-friendly cryopreservation
- 19 August 2025
- Published by Elsevier in Magnetic Resonance Imaging
- Vol. 123, 110510
A PRF-Based Multibaseline fitting model for temperature prediction
- 19 August 2025
- Published by Elsevier in Magnetic Resonance Imaging
- Vol. 123, 110510
A PRF-Based Multibaseline fitting model for temperature prediction
- 12 June 2025
- Published by Elsevier in Journal of Colloid and Interface Science
- Vol. 699 (Pt 1) , 138186
Controlled evaporation for microdroplet-based cryopreservation of cells and 3D cell aggregates
- 12 June 2025
- Published by Elsevier in Journal of Colloid and Interface Science
- Vol. 699 (Pt 1) , 138186
Controlled evaporation for microdroplet-based cryopreservation of cells and 3D cell aggregates
- Open Access
- 1 June 2025
- Published by Walter de Gruyter GmbH in Frigid Zone Medicine
- Vol. 5 (2) , 119-123
Cryopreservation as a versatile strategy for the construction and application of organoids
Organoids are three-dimensional structures derived from stem cells that recapitulate the gene expression profiles and functional characteristics of their tissue of origin, rendering them invaluable tools for disease modeling, drug screening, and precision medicine. Despite their promise, the widespread application of organoids is limited by extended culture durations and technical complexity. Cryopreservation has emerged as a critical strategy to overcome challenges related to the long-term storage and application of organoids, offering a range of preservation approaches tailored to organoid development. Nevertheless, conventional cryopreservation techniques encounter significant limitations when applied to organoids. To address these issues, the development of naturally derived, low-toxicity Cryoprotectants (CPAs), along with the optimization of CPA loading methods and refinement of cooling and warming protocols, is essential to mitigate cryoinjury. Looking forward, the comprehensive enhancement of cryopreservation technologies may facilitate the transformation of organoids into “off-the-shelf” products, enabling scalable production, batch standardization, and centralized distribution. Such advancements will lay the foundation for the establishment of Next-Generation Living Biobanks (NGLB).
- 1 June 2025
- Published by Walter de Gruyter GmbH in Frigid Zone Medicine
- Vol. 5 (2) , 119-123
Open AccessCryopreservation as a versatile strategy for the construction and application of organoids
Organoids are three-dimensional structures derived from stem cells that recapitulate the gene expression profiles and functional characteristics of their tissue of origin, rendering them invaluable tools for disease modeling, drug screening, and precision medicine. Despite their promise, the widespread application of organoids is limited by extended culture durations and technical complexity. Cryopreservation has emerged as a critical strategy to overcome challenges related to the long-term storage and application of organoids, offering a range of preservation approaches tailored to organoid development. Nevertheless, conventional cryopreservation techniques encounter significant limitations when applied to organoids. To address these issues, the development of naturally derived, low-toxicity Cryoprotectants (CPAs), along with the optimization of CPA loading methods and refinement of cooling and warming protocols, is essential to mitigate cryoinjury. Looking forward, the comprehensive enhancement of cryopreservation technologies may facilitate the transformation of organoids into “off-the-shelf” products, enabling scalable production, batch standardization, and centralized distribution. Such advancements will lay the foundation for the establishment of Next-Generation Living Biobanks (NGLB).